The quarter beat the market’s main earnings hurdle. Adjusted diluted EPS was $0.83 versus a published consensus near $0.68, and above the prior Q2 outlook’s $0.75 high end. Revenue of $1.981 billion was essentially in line with the roughly $1.98 billion expectation, so the upside came from profitability rather than sales.
| Metric | Q2 2026 | Q2 2025 / expectation | Read |
|---|---|---|---|
| Revenue | $1.981B | $1.943B; consensus ~$1.98B | In line with consensus; up 2% year over year (Income Statement; Financial Highlights) |
| Adjusted diluted EPS | $0.83 | $0.66; consensus ~$0.68 | Beat; above prior outlook high end of $0.75 (Adjusted EPS reconciliation) |
| Adjusted EBITDA | $249M | $210M | Up 19% year over year; above outlook high end (Adjusted EBITDA reconciliation) |
| P&S Adjusted EBITDA | $177M | $167M | Up 6%; margin improved to 25.5% from 25.1% (Segment non-GAAP results) |
| ADI Adjusted EBITDA | $103M | $107M | Down 4%; margin fell to 8.0% from 8.4% (Segment non-GAAP results) |
| Operating cash flow | $148M | $200M | Down $52M, mainly from separation costs, settlement payments and higher interest (Cash Flow statement) |
Products & Solutions carried the result, while ADI remained the weak spot. P&S revenue rose 4% and gross margin expanded to 43.6% from 42.9%, producing a 6% increase in segment Adjusted EBITDA despite higher investment and restructuring costs. ADI revenue grew only 1%, with Adjusted EBITDA down 4%; the reported margin benefit was helped by approximately $20 million of tariff refunds, making the underlying improvement less clean (Segment results — Products and Solutions; Segment results — ADI Global Distribution).
The new standalone outlook is the filing’s less obvious qualifier. Resideo now forecasts standalone 2026 revenue of $2.9 billion-$2.95 billion and Adjusted EBITDA of $605 million-$625 million (Standalone outlook). Against the first-half standalone presentation of approximately $1.49 billion revenue and $315 million EBITDA, that implies second-half revenue of roughly $1.41 billion-$1.46 billion and EBITDA of $290 million-$310 million. In other words, the Q2 beat does not translate into a higher run-rate: the company is guiding to modestly lower EBITDA in the back half after a $157 million standalone Q2 result.
The ADI spin-off improves the balance-sheet story but complicates the comparison. The $900 million dividend from ADI was used to repay $900 million of Resideo’s Term Loan B, with another approximately $200 million repayment expected by the end of Q3. ADI’s $400 million notes also moved off Resideo’s balance sheet after the August 3 separation (Liquidity and capital resources). Future quarters will show only Resideo’s Products & Solutions continuing operations, with historical ADI results reclassified as discontinued operations, so the next report—not this consolidated Q2—is the cleaner test of the standalone model.
The CFO appointment is a planned transition, not the main earnings signal. Shane Harrison becomes CFO and principal financial officer on September 1, replacing CEO Thomas Surran’s interim finance role. The filing provides a conventional executive package, including a $2 million initial equity award and $400,000 sign-on bonus, but gives no evidence of a financial-control issue or strategic disruption (Item 5.02; CFO appointment terms).
Read the original 8-K on SEC EDGAR ↗